Legal Opinion
Haller v. AstraZeneca Pharmaceuticals LP
District Court, M.D. Florida
Decided February 6, 2009No. Case 6:07-cv-15733-Orl-22DABPublishedCited by 10 opinions
1Opinion of the Court
Order
ANNE C. CONWAY, District Judge.
This cause comes before the Court for consideration of AstraZeneca’s Motion for Summary Judgment (Doc. 13), to which Plaintiff Haller has responded in opposition (Doc. 15). 1 Oral argument on the motion was held on January 13, 2009. Upon carefully considering the legal memoranda, exhibits, deposition testimony, relevant case law, and the oral argument, the Court determines that AstraZeneca’s motion is due to be GRANTED. 2
I. BACKGROUND
Seroquel, a prescription drug manufactured and sold by AstraZeneca Pharmaceuticals, was first approved for use in the United…
2Cases cited32 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Roderic R. McDowell v. Pernell BrownCourt of Appeals for the Eleventh Circuit · 2004
27 more not listed; retrieve them via the Exa API.
3Cited by10 opinions
- In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability LitigationDistrict Court, D. South Carolina · 2017
- Jones v. Novartis Pharmaceuticals Corp.District Court, N.D. Alabama · 2017
- In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability LitigationDistrict Court, D. South Carolina · 2017
- Hempstead v. Pfizer, Inc.District Court, D. South Carolina · 2015
- Barsness v. United StatesDistrict Court, W.D. Washington · 2025
5 more not listed; retrieve them via the Exa API.